04.02.2013 Views

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

official journal of the patent office - Controller General of Patents ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

(12) PATENT APPLICATION PUBLICATION<br />

(19) INDIA (21) Application No.: 00248/KOLNP/2005 A<br />

(22) Date <strong>of</strong> filing <strong>of</strong> Application: 23/02/2005 (43) Publication Date: 09/06/2006<br />

(54) Title <strong>of</strong> <strong>the</strong> invention: USE OF DIGOXIN IMMUNE FAB FOR THE REGULATION OF SODIUM/POTASSIUM ATPASE<br />

ACTIVITY IN PREECLAMPTIC AND ECLAMPTIC PATIENTS<br />

(51) International classification : A61K<br />

A61P 9/12<br />

39/395,<br />

(31) Priority Document No : 10/202,957<br />

10/292,338<br />

(32) Priority Date : 25/07/2002<br />

12/11/2002<br />

(33) Name <strong>of</strong> priority country : US<br />

(86) International Application No and : PCT/US03/023235<br />

Filing Date<br />

: & 24/07/2003<br />

(87) International Publication No : WO 04/011028<br />

(61) Patent <strong>of</strong> addition to Application No : NA<br />

Filed on : NA<br />

(62) Divisional to Application No : NA<br />

Filed on : NA<br />

(57) Abstract:<br />

A method <strong>of</strong> regulating a preeclamptic/eclamptic patient's<br />

sodium/potassium ATPase activity includes <strong>the</strong> administration <strong>of</strong><br />

digoxin immune Fab (ovine). Digoxin immune Fab (ovine) binds with<br />

<strong>the</strong> endogenous digitalis-like factor to prevent it from interfering with<br />

<strong>the</strong> functioning <strong>of</strong> <strong>the</strong> sodium/potassium ATPase, <strong>the</strong>reby allowing<br />

<strong>the</strong> patient's intracellular sodium and calcium to return to a more<br />

normal level. A method <strong>of</strong> controlling preeclampsia is also disclosed<br />

that includes <strong>the</strong> steps <strong>of</strong> providing a supply <strong>of</strong> digoxin immune Fab<br />

(ovine), calculating an appropriate dosage <strong>of</strong> <strong>the</strong> digoxin immune Fab<br />

(ovine) based on a patient's weight and using an assumed endogenous<br />

digitalis-like factor level, administering <strong>the</strong> appropriate dosage as an<br />

intravenous bolus, and repeating <strong>the</strong> administration <strong>of</strong> <strong>the</strong> appropriate<br />

dosage on a fixed schedule.<br />

(FIG). 1<br />

(71) Name <strong>of</strong> Applicant:<br />

ADAIR, CHARLES, DAVID.,<br />

Address <strong>of</strong> <strong>the</strong> Applicant:<br />

22 MOUNTAIN ORCHARD PATH,<br />

SIGNAL MOUNTAIN, TENNESSEE<br />

37377 USA.<br />

(72) Name <strong>of</strong> <strong>the</strong> Inventor:<br />

ADAIR, CHARELS, DAVID<br />

Filed U/S 5(2) before The <strong>Patents</strong> (Amendment)<br />

Act, 2005: NO<br />

The Patent Office Journal 09/06/2006 10983

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!